- Home
- SSII vs NVCT Comparison
SSII vs NVCT Comparison
Compare SSII & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SSII | NVCT |
|---|---|---|
| Founded | N/A | 2020 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.3M | 617.7M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SSII | NVCT |
|---|---|---|
| Price | $2.61 | $21.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $35.40 |
| AVG Volume (30 Days) | 67.1K | ★ 159.2K |
| Earning Date | 10-27-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.45 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $42,484,747.00 | N/A |
| Revenue This Year | $40.29 | N/A |
| Revenue Next Year | $27.85 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 105.74 | N/A |
| 52 Week Low | $2.61 | $5.55 |
| 52 Week High | $10.00 | $29.28 |
Technical Indicators
Market Signals| Indicator | SSII | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 26.72 | 48.70 |
| Support Level | N/A | $19.78 |
| Resistance Level | $4.16 | $23.15 |
| Average True Range (ATR) | 0.20 | 1.43 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 3.29 | 44.69 |
Price Performance
Historical ComparisonAbout SSII SS Innovations International Inc.
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.